Formulation and Characterization of Lipid-Coated Tobramycin Particles for Dry Powder Inhalation

Deposition of particles in the human respiratory tract in the size range 0.005–15 μm

J. Heyder, J. Gebhart, G. Rudolf et al. · Journal of Aerosol Science · 1986 · 1K citations

Natural Sciences, Physiology, Pulmonology +13

Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung

Jeffrey O.-H Sham, Yu Zhang, Warren H. Finlay et al. · International Journal of Pharmaceutics · 2003 · 274 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +14

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

M.E. Hodson, C. G. Gallagher, John R. W. Govan · European Respiratory Journal · 2002 · 268 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.

Paul M. Mendelman, Arnold L. Smith, Jack Lévy et al. · PubMed · 1985 · 218 citations

Medicine, Microbiology, Pharmacology +13

Droplet and Particle Size Relationship and Shell Thickness of Inhalable Lactose Particles During Spray Drying

Jessica Elversson, Anna Millqvist‐Fureby, Göran Alderborn et al. · Journal of Pharmaceutical Sciences · 2003 · 218 citations

Engineering, Food Science, Materials Science +16